Showing results (71-80 of 125) with videos related to
Sort By:
Pageof 13
Journal of Clinical Gastroenterology|October 1, 1990
Clinical significance of cholelithiasis in patients with decompensated cirrhosisG Finucci, M Tirelli, S Bellon, et al.European Journal of Clinical Investigation|June 1, 1981
Evaluation of renal tubular damage in liver cirrhosis by urinary enzymes and beta-2-microglobulin excretionsA Gatta, P Amodio, A Frigo, et al.Klinische Wochenschrift|June 15, 1988
Fibronectin decrease in liver cirrhosis is related to spleen sizeV de Angelis, M Zambon, L Toffolo, et al.Digestive Diseases and Sciences|September 1, 1988
Hemodynamic changes of systemic, hepatic, and splenic circulation following triglycyl-lysin-vasopressin administration in alcoholic cirrhosisC Merkel, A Gatta, M Bolognesi, et al.International Journal of Clinical Pharmacology Research|January 1, 1985
Use of a nonselective beta-blocker, nadolol, in the treatment of portal hypertension in cirrhoticsA Gatta, D Sacerdoti, C Merkel, et al.The American Review of Respiratory Disease|June 1, 1988
Fatal asthma in a subject sensitized to toluene diisocyanateL M Fabbri, D Danieli, S Crescioli, et al.Thorax|September 9, 2009
Bronchial vascular remodelling in patients with COPD and its relationship with inhaled steroid treatmentA Zanini, A Chetta, M Saetta, et al.Journal of Chemotherapy (Florence, Italy)|August 28, 1999
A randomized trial of cefepime and ceftazidime for the treatment of community-acquired pneumoniaP Bonfitto, V Lamorgese, T De Vietro, et al.International Journal of Clinical Pharmacology Research|January 1, 1988
Verapamil pharmacokinetics and liver function in patients with cirrhosisG F Finucci, R Padrini, D Piovan, et al.British Journal of Clinical Pharmacology|June 1, 1986
Effect of nadolol on liver haemodynamics and function in patients with cirrhosisC Merkel, D Sacerdoti, G F Finucci, et al.Pageof 13